Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer

Published:2009-11 Issue:8 Volume:19 Page:1446-1453
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Seliger Gregor,Mueller Lutz P.,Kegel Thomas,Kantelhardt Eva J.,Grothey Axel,Groe Regina,Strauss Hans-Georg,Koelbl Heinz,Thomssen Christoph,Schmoll Hans-Joachim

Publisher

BMJ

Subject

Obstetrics and Gynecology,Oncology

Reference55 articles.

1. Ovarian cancer

2. Second-Line Treatment of Ovarian Cancer

3. Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer

4. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Management of Patients with Early-Stage Ovarian Cancer;Advances in Diagnosis and Management of Ovarian Cancer;2022

2. Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study;International Journal of Gynecologic Cancer;2019-01

3. Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution;BMC Palliative Care;2018-08-07

4. Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer;Gynecologic Oncology;2015-09

5. Oxaliplatin for the treatment of ovarian cancer;Expert Opinion on Investigational Drugs;2015-06-30